About DiligenceBio
DiligenceBio is a company based in Puducherry (India) founded in 2017. It operates as a B2B. The company has 20 employees as of March 31, 2021. DiligenceBio offers products and services including Toxicity Studies, Mutagenicity Studies, Ecotoxicity Studies, and Phys-Chem Studies. DiligenceBio operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, PhenoVista, BCI Pharma and Quantumcyte, among others.
- Headquarter Puducherry, India
- Employees 20 as on 31 Mar, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Diligence Bio Private Limited
- Date of Incorporation 21 Oct, 2016
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$159.66 K (USD)1192.43as on Mar 31, 2021
-
Net Profit
-$62.78 K (USD)67.23as on Mar 31, 2021
-
EBITDA
$18.36 K (USD)116.56as on Mar 31, 2021
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
20
as on Mar 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DiligenceBio
DiligenceBio offers a comprehensive portfolio of products and services, including Toxicity Studies, Mutagenicity Studies, Ecotoxicity Studies, and Phys-Chem Studies.
Conducts regulatory tests for acute oral and dermal toxicity compliance
Performs assays like Ames test for mutation detection
Evaluates impacts on fish, bees, and earthworms per guidelines
Analyzes properties like viscosity and stability for products
Funding Insights of DiligenceBio
Detailed funding history for DiligenceBio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DiligenceBio
Investment portfolio details for DiligenceBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DiligenceBio
Detailed financials for DiligenceBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diligencebio Comparisons
Peer comparison for DiligenceBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DiligenceBio
DiligenceBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, PhenoVista, BCI Pharma and Quantumcyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| Locked | Locked | Locked |
A CRO that provides phenotypic assay development and screening services.
|
|
| Locked | Locked | Locked |
Contract research services in cancer and neuroinflammation are offered.
|
|
| Locked | Locked | Locked |
Drug assay systems for cancer treatment are developed and provided.
|
|
| Locked | Locked | Locked |
Custom human cell engineering and drug discovery services are provided.
|
Detailed competitors of DiligenceBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diligencebio
Complete news archive for DiligenceBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DiligenceBio
DiligenceBio was founded in 2017.
DiligenceBio is headquartered in Puducherry, India. It is registered at Puducherry, Puducherry, India.
As of Mar 31, 2021, the latest employee count at DiligenceBio is 20.
Annual revenue of DiligenceBio is $159.66K as on Mar 31, 2021.
DiligenceBio is a GLP-certified contract research organization based in Pondicherry and Chennai, India, specializing in regulatory toxicology studies for pharmaceutical, biotechnology, and agrochemical industries. It conducts tests like acute toxicity and ecotoxicity to meet international standards, ensuring compliance with OECD guidelines. The company serves sponsors by offering quick turnaround, effective project management, and technical expertise through experienced professionals.
DiligenceBio's top competitors include ImmunoSCAPE, Quantumcyte and Reaction Biology.
DiligenceBio offers Toxicity Studies, Mutagenicity Studies, Ecotoxicity Studies, and Phys-Chem Studies.